Medicine for treating myocarditis

Abstract

The invention relates to a medicine for treating myocarditis. The medicine is prepared from a traditional Chinese medicine part and a western medicine part; the traditional Chinese medicine part comprises 20g of poria cocos, 15g of cassia twig, 15-20g of astragalus membranaceus, 10-15g of codonopsis pilosula, 10-15 g of caulis spatholobi, 9-12 g of loranthus parasiticus, 6-9 g of peach kernel, 6-9g of safflower, 10-15 g of angelica sinensis, 10-15 g of atractylodes macrocephala, 15-20 g of rhizoma alismatis, 10-15 g of fingered citron, 10-15 g of allium macrostemon, 10-12 g of trichosanthes kirilowii, 8-12g of fried jujube kernel, 10-12g of semen boitae, 6-9g of radix sophorae flavescentis, 9-12g of poria with hostwood and 9g of liquorice root; the western medicine part comprises vitaminB12, coenzyme A, inosine and cytochrome C. when the medicine is used for a patient with myocarditis caused by viral infection, antibiotics and vitamin C should be added. The above six western medicines have the effects of improving myocardial metabolism, sterilizing and inhibiting bacteria. The traditional Chinese and western medicine method is adopted for treating myocarditis, the treatment effect directly reaches the focus, and the recurrence rate is low.

Description

technical field [0001] The patent of the invention belongs to the technical field of traditional Chinese medicine, in particular to a medicament for treating myocarditis. Background technique [0002] Myocarditis is a kind of heart disease. Children and adults under the age of 40 are frequent people. Myocarditis is an inflammatory reaction of myocardial cells, endocardium and epicardium caused by various pathogenic bacteria. The pathological changes of myocarditis are limited of. Its clinical manifestations vary, mainly: palpitations, fatigue, chest tightness and dizziness. Treatment methods are mainly divided into drug therapy and non-drug therapy. Non-drug treatment is mainly based on surgery, but due to the particularity of myocarditis, surgical treatment is not effective, and there are certain risks; now drug treatment is mainly based on Western medicine, taking antibacterial, antifungal and antiprotozoal drugs However, the above-mentioned drugs are mainly antiviral d...

AI Technical Summary

Problems solved by technology

Non-drug treatment is mainly based on surgery, but due to the particularity of myocarditis, surgical treatment is not effective and there are certain risks; now drug treatment is mainly based on western medicine, taking antibacterial, antifungal and antiprotozoal drugs However, the above-mentioned drugs are mainly antiviral drugs, and the treatment is mainly palliative, and the effect on the regulation and recovery of cardiac function is not obvious